We did, however, not assess, whether the reduction of barrier properties under the synergistic influence of TNF‐α and INF‐γ was caused by panopsis, as also seen in COVID‐19 patients, or stimulation of other cellular pathways such as NF‐κB.[75, 76] Further possible applications for “Arlo” beyond the use in classical biopharmaceutical experiments were revealed by the exploration of the RNA‐Seq data for possible protein‐protein interactions using the STRING resource. The gene discussed is TNF; the disease is COVID-19.